All Categories
    Filters
    Preferences
    Search
    Brand: Cook-Waite

    Cook-Waite Carbocaine® 3% (mepivacaine hydrochloride), 50x1.7ml Carp/Bx

    Login For Price
    The product contains 3% Mepivacaine HCl injection without vasoconstrictor.

    The mild vasodilating properties of Mepivacaine provides a longer duration than other drugs without vasoconstrictor (plain). Carbocaine ® 3% is part of the complete line of Cook-Waite products.

    Indications:

    • CARBOCAINE is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients.

    Key Features:

    • Formulation without vaso-constrictor for specific medical situations.
    • Fast onset: 30 to 120 seconds in the maxilla and 1 to 4 minutes for the mandible.
    • Duration: will ordinarily provide pulpal anesthesia of about 20 minutes in the maxilla, and about 40 minutes in the mandible.
    • No-methylparaben formulation to avoid allergic reactions on sensitive patients.
    • Terminal sterilization of product/cartridges for safe use.
    • 100 percent latex free components to help reduce allergic responses.
    • Mylar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakage.
    • Cartridges packed 10 to a blister tray to avoid glass to glass contact, hence reducing breakage.

    Risk information:

    • Reactions to Cook-waite Carbocaine are characteristic of those associated with other amide-type local anesthetics. A major cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, inadvertent intravascular injection or slow metabolic degradation. It is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of mepivacaine solutions. Local anesthetics should be employed only by clinicians who are well versed in diagnosis and management of dose-related toxicity and other acute emergencies which might arise from the block to be employed, and then only after insuring the immediate availability of oxygen, other resuscitative drugs, cardiopulmonary resuscitative equipment, and the personnel resources needed for proper management of toxic reactions and related emergencies. It contains potassium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Please see package insert for prescribing information.

    Package contains:

    • 50 cartridges – A box of 5 blisters of 10 x 1.7 ml glass cartridges
    Part number: 2474174
    Customers who bought this item also bought

    Ultracaine® D-S Forte Articaine HCI 4% w/ 1:100,000 Epi (Blue), 100x1.7ml Carp/Bx

    Ultracaine® is the world’s original articaine and is exclusively available through HANSAmed. Cartridges with latex-free closures and recyclable all-cardboard packaging.

    Ultracaine® is the world’s original articaine and one of HANSAmed’s key products. It is available as an injectable local anesthetic and has been sold exclusively in Canada through HANSAmed since 1999.

    Ultracaine D-S Forte contains 4% articaine hydrochloride (40 mg/mL) with 1:100,000 epinephrine (0.006 mg/mL epinephrine hydrochloride, which corresponds to 0.005 mg/mL (epinephrine as a free base), sodium metabisulphite (0.50 mg/mL) as antioxidant, and water for injection.

    User Benefits

    • Epinephrine: 1:100,000 straight epinephrine; Ultracaine® D-S Forte is a longer lasting anesthetic than Ultracaine® D-S due to the higher concentration of epinephrine
    • Pulpal Anesthesia: Provides 60-75 minutes of safe and effective pulpal anesthesia
    • Soft Tissue Anesthesia: Provides 180-360 minutes of safe and effective soft tissue anesthesia
    • Onset: 1-2 minute infiltration; 2-3 minutes block
    • Half Life: 27 minutes half-life

    Indications & Clinical Use

    • Ultracaine D-S (articaine with epinephrine) solutions for injection are indicated for Infiltration anesthesia and nerve block anesthesia in clinical dentistry.
    • Geriatrics (>65 years of age): elderly patients should be given reduced doses commensurate with their age and physical condition.
    • Pediatrics (<4 years of age): the use of Ultracaine D-S and Ultracaine D-S Forte (articaine with epinephrine solutions) in children under the age of 4 years is not recommended.

    Package contains:

    • 100 x 1.7mL carpules of Ultracaine® D-S Forte Articaine HCI 4% w/ 1:100,000 Epi (Blue)

    Ultracaine® D-S Regular Articaine HCI 4% w/ 1:200,000 Epi (Green), 100x1.7ml Carp/Bx

    Ultracaine® is the world's original articaine and is exclusively available through HANSAmed. Cartridges have latex-free closures and recyclable all-cardboard packaging.

    Ultracaine® is the world’s original articaine and one of HANSAmed’s key products. It is available as an injectable local anesthetic and has been sold exclusively in Canada through HANSAmed since 1999.

    Ultracaine D-S contains 4% articaine hydrochloride (40 mg/mL) with 1:200,000 epinephrine (0.006 mg/mL epinephrine hydrochloride, which corresponds to 0.005 mg/mL epinephrine as a free base), sodium metabisulphite (0.50 mg/mL) as antioxidant, and water for injection.

    User Benefits

    • Epinephrine: 1:200,000 straight epinephrine
    • Pulpal Anesthesia: Provides 45-60 minutes of safe and effective pulpal anesthesia
    • Soft Tissue Anesthesia: Provides 120-300 minutes of safe and effective soft tissue anesthesia
    • Onset: 2-3 minutes onset
    • Half Life: 27 minutes half-life

    Indications & Clinical Use

    • Ultracaine D-S (articaine with epinephrine) solutions for injection are indicated for infiltration anesthesia and nerve block anesthesia in clinical dentistry.
    • Geriatrics (>65 years of age): elderly patients should be given reduced doses commensurate with their age and physical condition.
    • Pediatrics (<4 years of age): the use of Ultracaine D-S and Ultracaine D-S Forte (articaine with epinephrine solutions) in children under the age of 4 years is not recommended.

    Package contains:

    • 100 x 1.7mL carpule of Ultracaine® D-S Regular Articaine HCI 4% w/ 1:200,000 Epi (Green)

    Cook-Waite Lidocaine HCl 2% w/ Epi 1:100,000, (Red) 50 1.7ml Carp/Bx

    The product contains 2% Lidocaine HCl injection with 1:100,000 epinephrine bitartrate. This is a versatile local anesthetic of intermediate duration

    Indications:

    • Local dental anesthesia by nerve block or infiltration

    Key Features:

    • Lidocaine when used for infiltration will have an average onset time of less than two minutes and a duration of about 60 minutes. When used for nerve blocks the average onset time is 2 to 4 minutes and will provide about 90 minutes of pulpal anesthesia.
    • No-methylparaben formulation to avoid allergic reactions on sensitive patients.
    • 100 percent latex free components to help reduce allergic responses.
    • Terminal sterilization of product/cartridges for safe use.
    • Mylar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakage.
    • Cartridges packed 10 to a blister tray to avoid glass to glass contact, hence reducing breakage.

    Risk information:

    • Reactions to Lidocaine are characteristic of those associated with other amide-type local anesthetics. A major cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, inadvertent intravascular injection or slow metabolic degradation. Lidocaine is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of lidocaine solutions. Local anesthetics should be employed only by clinicians who are well versed in diagnosis and management of dose-related toxicity and other acute emergencies which might arise from the block to be employed, and then only after insuring the immediate availability of oxygen, other resuscitative drugs, cardiopulmonary resuscitative equipment, and the personnel resources needed for proper management of toxic reactions and related emergencies. Lidocaine contains potassium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Please see package insert for prescribing information.

    Package contains:

    • 50 cartridges – A box of 5 blisters of 10 x 1.7 ml glass cartridges

    ANESTAject Plastic Hub 30G X-Short (13mm), 100 Needle/Bx

    These are HANSAmed’s exclusive brand of plastic hub needles: A pre-threaded, plastic hub needle that fits to your syringe as easily and securely as metal hub needles.

    Package contains:

    • 100 needles per box of ANESTAject Plastic Hub 30G X-Short (13mm)

    Geistlich Bio-Gide® 13x25mm, 1 U/Bx

    Geistlich Bio-Gide® is the leading collagen membrane in North America for oral tissue regeneration. It is used in combination with a bone substitute such as Geistlich Bio-Oss® or Geistlich Bio-Oss Collagen®. Geistlich Bio-Gide® integrates with surrounding tissues to protect the initial coagulum. With its unique bilayer structure, Geistlich Bio-Gide® not only prevents ingrowth of soft tissue into the augmented site, but then optimally degrades to allow for the cascade of biologic events leading to regeneration.

    Geistlich Bio-Gide® is naturally resorbable therefore a second surgery for removal of the membrane is not required. As it simplifies the surgical technique, and exhibits excellent wound healing properties, Geistlich Bio-Gide® has fundamentally changed dental bone regeneration.

    Leading clinicians rely on Geistlich Bio-Gide® for:

    • Excellent tissue integration and undisturbed bone regeneration compared to using a bone substitute alone
    • Native collagen structure results in fewer dehiscences compared with other available membranes
    • Fully resorbable, no second surgery required for membrane removal
    • Predictable outcomes in the esthetic zone
    • Long-term data demonstrates predictable results in Guided Bone Regeneration (GBR) treatments when Geistlich Bio-Gide® is used in combination with Geistlich Bio-Oss®

    Indications:

    • Augmentation around implants placed in immediate and delayed extraction sockets
    • Localized ridge augmentation for later implantation
    • Alveolar ridge reconstruction for prosthetic treatment
    • Filling of bone defects after root resection, cystectomy, removal of retained teeth
    • GBR in dehiscence defects; and GTR procedures in periodontal defects

    Application of Geistlich Bio-Gide® is easy:

    • Measure the defect with a periodontal probe
    • Trim the dry collagen membrane to the desired shape and size
    • Apply dry with the rough side facing the defect
    • Moisten the membrane in situ with blood from the defect

    Geistlich Bio-Gide® is available in three convenient sizes:

    • 13 x 25 mm
    • 25 x 25 mm
    • 40 x 50 mm

    and a combination kit:

    • Geistlich Combi-Kit Collagen - Geistlich Bio-Gide® 16 x 22 mm with Geistlich Bio-Oss® 100 mg

    The package contains:

    • 1 membrane of Geistlich Bio-Gide® 13x25mm
    *
    *
    *